Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2006; 12(47): 7585-7590
Published online Dec 21, 2006. doi: 10.3748/wjg.v12.i47.7585
Published online Dec 21, 2006. doi: 10.3748/wjg.v12.i47.7585
Figure 1 Schedule of preoperative chemoradiotherapy (CRT).
Figure 2 Immunohistochemical detection of CXCR4 in ESCC specimens.
A: Null expression (A1: × 40; A2: × 200); B: Strong expression (B1: × 40; B2: × 200).
Figure 3 Overall survival in ESCC patients with no residual tumor or null CXCR4 expression and those with positive CXCR4 expression.
Figure 4 Overall survival in ESCC patients with null or positive CXCR4 expression.
- Citation: Koishi K, Yoshikawa R, Tsujimura T, Hashimoto-Tamaoki T, Kojima S, Yanagi H, Yamamura T, Fujiwara Y. Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer. World J Gastroenterol 2006; 12(47): 7585-7590
- URL: https://www.wjgnet.com/1007-9327/full/v12/i47/7585.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i47.7585